Johnson & Johnson begins testing coronavirus vaccine in Britain

In the British Isles, 6 thousand volunteers will take part in them.

The American Company Johnson & Johnson (J&J) is starting clinical trials of its coronavirus vaccine in the UK at a late, third stage of the drug’s research. This was reported on Monday by the Financial Times.

In the British Isles, 6 thousand volunteers will take part in tests in several countries, which involve almost 30 thousand people.

Under an agreement reached by J&J with the British government, volunteers will be given a placebo or experimental Ad26COV2 vaccine first, followed by a second dose of the drug or placebo 57 days later.

The US Company does not rule out that if the vaccine proves its effectiveness and safety, the first batches will be available for certification in early 2021.

Earlier, late-stage trials of a vaccine by the American biotech company Novavax and the British-Swedish pharmaceutical company AstraZeneca, which is developing the drug in collaboration with scientists from the University of Oxford, were launched in the United Kingdom.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: